Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) Stock Ticker
DMAA right now
Market factors today
Unlock the full DMAA picture
About Drugs Made In America Acquisition Corp. Ordinary Shares
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.
DMAA stock facts
| Ticker symbol | DMAA |
| Exchange | NASDAQ Global Select |
| Sector | Financial Services |
| Industry | Shell Companies |
| Market cap | $263.2M |
| CEO | Roger Bendelac |
| Employees | 2 |
| Headquarters | New York, NY, US |
| IPO date | 2025-01-27 |
| Website | dmaacorp.com |
What you can see for DMAA on Tickr
Live DMAA price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the DMAA report.
Rankings
FAQ
What is the ticker symbol for Drugs Made In America Acquisition Corp. Ordinary Shares?
The ticker symbol for Drugs Made In America Acquisition Corp. Ordinary Shares is DMAA, listed on the NASDAQ Global Select.
What is DMAA?
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.